RO7049665
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for RO7049665, covering 2023-09-18 to 2024-02-15. Get the full timeline:
Most recent: Clinical Trial Update: Double-Blinded, Placebo-Controlled Phase 1b Study for Safety, PK, Efficacy, PD of RO7049665 in Participants With Ulcerative Colitis (UC) [Phase 1]